Medicare Enrolled

Dr. Amy Scanlon, APN, FNP-BC

Physician Assistant · Deptford, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1450 ALMONESSON RD STE 125, Deptford, NJ 08096
8562230965
In practice since 2014 (12 years)
NPI: 1922426717 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Scanlon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scanlon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Scanlon

Dr. Amy Scanlon is a physician assistant in Deptford, NJ, with 12 years of NPI registration. Based on federal Medicare data, Dr. Scanlon performed 2,373 Medicare services across 495 unique beneficiaries.

Between the years covered by Open Payments, Dr. Scanlon received a total of $12,781 from 43 pharmaceutical and/or device companies across 905 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Scanlon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 4% volume in NJ $12,781 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,373
Medicare services
Top 4% in NJ for physician assistant
495
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~198 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,500 $18 $43
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
534 $83 $281
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
287 $58 $199
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
52 $10 $49
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,781
Total received (2021-2024)
Avg $3,195/year across 4 years
Top 1% in NJ for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
905
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,781 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,747
2023
$3,188
2022
$3,902
2021
$2,944

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$307
Ascensia Diabetes Care Us Inc.
$219
Amneal Pharmaceuticals LLC
$219
Novo Nordisk Inc
$196
Lilly USA, LLC
$189
Antares Pharma, Inc.
$183
Bayer Healthcare Pharmaceuticals Inc.
$179
Xeris Pharmaceuticals, Inc.
$168
CeQur Corporation
$119
RECORDATI_RARE_DISEASES_INC.
$108
Mannkind Corporation
$108
Tolmar, Inc.
$95
Amgen Inc.
$83
Corcept Therapeutics
$77
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Dexcom, Inc.
$71
Tandem Diabetes Care, Inc.
$62
Insulet Corporation
$58
SANOFI-AVENTIS U.S. LLC
$51
PFIZER INC.
$44
Radius Health, Inc.
$43
IBSA Pharma Inc.
$32
Acella Pharmaceuticals, LLC
$16
Verity Pharmaceuticals Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
ABBVIE INC.
$15
Top 3 companies account for 27.1% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$1,312
MannKind Corporation
$1,295
Mannkind Corporation
$1,274
Amneal Pharmaceuticals LLC
$736
Abbott Laboratories
$714
Lilly USA, LLC
$603
Bayer Healthcare Pharmaceuticals Inc.
$596
Xeris Pharmaceuticals, Inc.
$557
Corcept Therapeutics
$553
SANOFI-AVENTIS U.S. LLC
$532
Ascensia Diabetes Care Us Inc.
$502
CeQur Corporation
$489
Boehringer Ingelheim Pharmaceuticals, Inc.
$438
Amgen Inc.
$391
Bayer HealthCare Pharmaceuticals Inc.
$313
AstraZeneca Pharmaceuticals LP
$261
Intuity Medical Inc
$196
Antares Pharma, Inc.
$183
Dexcom, Inc.
$163
Tolmar, Inc.
$156
Amarin Pharma Inc.
$140
Insulet Corporation
$134
Radius Health, Inc.
$117
IBSA Pharma Inc.
$116
RECORDATI_RARE_DISEASES_INC.
$108
Alexion Pharmaceuticals, Inc.
$102
Zealand Pharma US, Inc.
$93
Medtronic, Inc.
$89
Tandem Diabetes Care, Inc.
$87
Kowa Pharmaceuticals America, Inc.
$69
Merck Sharp & Dohme Corporation
$67
ABBVIE INC.
$60
PFIZER INC.
$58
AbbVie Inc.
$57
Supernus Pharmaceuticals, Inc.
$50
Currax Pharmaceuticals LLC
$41
Clarus Therapeutics Inc.
$40
Acella Pharmaceuticals, LLC
$16
Verity Pharmaceuticals Inc.
$15
Astellas Pharma US Inc
$15
Rhythm Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme LLC
$14
Azurity Pharmaceuticals, Inc.
$13
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · BASAGLAR · CONTRAVE · CeQur Simplicity · Dexcom G6 Transmitter · ELIGARD · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · INPEN SMART INSULIN DELIVERY SYSTEM · JANUVIA · JARDIANCE · JATENZO · KEVEYIS · Kerendia · Korlym · LICART · Livalo · MINIMED 770G · MOUNJARO · Minimed 770G System · NP Thyroid 60 · Omnipod · Otezla · Ozempic · Pogo Automatic Blood Glucose Monitoring System · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tymlos · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Wegovy · XYOSTED · ZEGALOGUE · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for physician assistant in NJ.

Looking for a physician assistant in Deptford?
Compare physician assistants in the Deptford area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
1,292
Per 100K population
424.3
County median income
$102,807
Nearest hospital
NORTHBROOK BEHAVIORAL HEALTH HOSPITAL
5.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Scanlon is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NJ), with low-engagement industry engagement in the top 1% of NJ peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Scanlon experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Scanlon performed 1,500 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Scanlon receive payments from pharmaceutical companies?
Yes. Dr. Scanlon received a total of $12,781 from 43 companies across 905 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Scanlon's costs compare to other physician assistants in Deptford?
Dr. Scanlon's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Scanlon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →